IgA Nephropahty List of articles

ELIQUENT Japan > IgA Nephropahty

2026.02.04

Medicine,capsules,isolated,from,the,white,background.,3d,rendering

Points to Consider for the Efficacy Evaluation of Drugs for IgA Nephropathy (Early Consideration)

Introduction to Regulatory Considerations According to the document “Points to Consider for the Efficacy Evalu […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570